Ocumension Therapeutics (HKSE:01477) Other Stockholders Equity : HK$17.4 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Ocumension Therapeutics Other Stockholders Equity?

Ocumension Therapeutics's Other Stockholders Equity for the quarter that ended in Dec. 2023 was HK$17.4 Mil.

Ocumension Therapeutics's quarterly Other Stockholders Equity increased from Dec. 2022 (HK$-352.7 Mil) to Jun. 2023 (HK$-52.9 Mil) and increased from Jun. 2023 (HK$-52.9 Mil) to Dec. 2023 (HK$17.4 Mil).

Ocumension Therapeutics's annual Other Stockholders Equity declined from Dec. 2021 (HK$-248.3 Mil) to Dec. 2022 (HK$-352.7 Mil) but then increased from Dec. 2022 (HK$-352.7 Mil) to Dec. 2023 (HK$17.4 Mil).

Ocumension Therapeutics Other Stockholders Equity Historical Data

The historical data trend for Ocumension Therapeutics's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ocumension Therapeutics Other Stockholders Equity Chart

Ocumension Therapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Other Stockholders Equity

Get a 7-Day Free Trial

-2,301.72

2,966.29

-248.31

-352.65

17.45

Ocumension Therapeutics Semi-Annual Data
	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Other Stockholders Equity	Get a 7-Day Free Trial						-248.31	3,461.26	-352.65	-52.92	17.45

Ocumension Therapeutics Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Ocumension Therapeutics Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Ocumension Therapeutics's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Ocumension Therapeutics (HKSE:01477) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Ocumension Therapeutics (HKSE:01477) » Definitions » Other Stockholders Equity

Comparable Companies

Traded in Other Exchanges

5DG:Germany

Address

No. 1858 Yinzhongnan Road, Guoxiang Subdistrict, Wuzhong District, Suzhou, Jiangsu, CHN

Website

http://www.ocumension.com

Ocumension Therapeutics is an ophthalmic pharmaceutical platform company identifying, developing, and commercializing ophthalmic therapies. It provides a pharmaceutical total solution to address unmet ophthalmic medical needs in China. Its product candidates include OT-401 (YUTIQ), OT-101, OT-301 (NCX 470), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-202, OT-503 (NCX 4251), OT-701, Ou Qin, Brimonidine tartrate eye drop, 0.5% moxifloxacin eye drop, OT-601-C, OT-302, OT-1301, T-1601, and OT-1602.

Ocumension Therapeutics (HKSE:01477) Headlines

No Headlines